OP
ISLE

Omni Partners’s Isleworth Healthcare Acquisition Corporation Common stock ISLE Stock Holding History

Omni Partners’s Portfolio ISLE Stock Details ISLE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$640K Buy
+66,062
New +$638K 0.03% 180

Other funds holding ISLE

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Omni Partners's ISLE Position: Q1 2021 in Review

Omni Partners opened a new position in Isleworth Healthcare Acquisition Corporation Common stock (ISLE) in Q1 2021: 66,062 shares worth $640K. The stake represents 0.03% of the portfolio and ranks #180 among its holdings.

67 funds tracked by Wall St. Rank hold ISLE as of Q1 2021.

  • Omni Partners held 66,062 shares of Isleworth Healthcare Acquisition Corporation Common stock worth $640K as of Q1 2021.
  • Isleworth Healthcare Acquisition Corporation Common stock was a new Omni Partners position in Q1 2021.
  • Isleworth Healthcare Acquisition Corporation Common stock made up 0.03% of Omni Partners's portfolio in Q1 2021, its #180 holding.
  • 67 funds tracked by Wall St. Rank held Isleworth Healthcare Acquisition Corporation Common stock as of Q1 2021.

Based on Omni Partners's 13F filing for Q1 2021, filed 17 May 2021.